Helping TMJ degeneration by focusing on aging cells
Targeting P21 positive senescent cells for alleviating TMJ degeneration
This research explores a new way to treat painful jaw joint degeneration by focusing on specific aging cells that contribute to the problem.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Nebraska Medical Center NIH-funded |
| Lab location | 1 site (Omaha, United States) |
| Project ID | NIH-11184247 on NIH RePORTER |
What this research studies
Temporomandibular Joint (TMJ) degeneration causes significant pain and difficulty for over 20 million people in the U.S., often linked to obesity, aging, and mechanical stress. Currently, there isn't an effective treatment for this condition, especially in older or obese individuals. This project aims to change that by looking at a specific type of aging cell, called p21 high cells, which are believed to play a key role in TMJ degeneration. By understanding and potentially removing these cells, we hope to find a new way to reduce the pain and improve the quality of life for those affected.
Who could benefit from this research
Good fit: Patients experiencing pain and degeneration in their temporomandibular joint, particularly those whose condition is linked to obesity or aging, could potentially benefit from future treatments developed from this work.
Not a fit: Patients whose TMJ issues are not related to cell aging or the specific mechanisms explored in this basic science research may not directly benefit from this particular approach.
Why it matters
Potential benefit: If successful, this research could lead to a new and effective treatment for TMJ degeneration, offering relief from chronic pain and improving jaw function.
How similar studies have performed: This proposal uses a highly innovative approach to target specific cells, suggesting it is a novel strategy rather than a refinement of existing successful treatments.
Where this research is happening
Omaha, United States
- University of Nebraska Medical Center — Omaha, United States (Active)
Researchers
- Principal investigator: Yadav, Sumit — University of Nebraska Medical Center
- Study coordinator: Yadav, Sumit
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.